Form D · Biotechnology
MABVAX THERAPEUTICS HOLDINGS, INC.
San Diego, CA · CIK 0001109196
Offering snapshot reported May 15, 2018 · SEC filing
- Reported sold
- $830K Offering amount: $860K
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2018 | Initial | $830,000 | No comparison | 11 | SEC filing |
| Feb 13, 2018 | Initial | $2,750,000 | No comparison | 13 | SEC filing |
| Apr 9, 2015 | Initial | $11,614,501 | No comparison | 49 | SEC filing |
| Jul 10, 2014 | Initial | $5,185,000 | No comparison | 55 | SEC filing |
| May 22, 2014 | Initial | $4,581,250 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312459
Source: Form D, filed May 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jim J. Antonopoulos | Director |
| Edward W. Cantrall | Director |
| Kenneth M. Cohen | Director |
| Jeffrey F. Eisenberg | Director |
| Steven R. Goldring | Director |
| J. David Hansen | Director, Executive |
| J. David Hansen | Director, Executive |
| Gregory P. Hanson | Executive |
| Robert Hoffman | Director |
| William P. Kaplan | Executive |
| Philip O. Livingston | Director |
| Paul W. Maffuid | Executive |
| Paul V. Maier | Director |
| Richard B. Newman | Director |
| Jeffrey Ravetch | Director |
| Paul Resnick | Executive |
| Steven R. Schow | Executive |
| Thomas Varrano | Director |
| Thomas C. Varvaro | Director |
| Wendy K. Wee | Executive |
| Michael M. Wick | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11535 Sorrento Valley Rd. Suite 400
San Diego, CA, 92121
San Diego, CA, 92121